Universidad de Alcalá-OTRI

Nanoconjugates formed by dendritic molecules and peptides as antitumor agents against advanced prostate cancer.

Posted by Universidad de Alcalá-OTRIResponsive · Patents for licensing · Spain

Summary of the technology

The Research Group in "Dendrimers for Biomedical Applications" of the University of Alcalá presents a new invention that refers to the formation of nanoconjugates with antitumor activity, mainly against advanced prostate cancer. Nanoconjugates are composed of dendritic systems (dendrimers and dendrons) and neuropeptides. The dendritic molecules are mainly of carbosilane structure and with ammonium functions in the periphery. And the peptides are preferably of the glucagon / secretin family (VIP, GHRH, PACAP…etc.)

The research group seeks companies from the Biomedicine, Pharmaceutical and Health sector, to establish licensing agreements, cooperation agreements or commercial agreements with technical assistance.

Universidad de Alcalá-OTRI
Universidad de Alcalá-OTRI
Universidad de Alcalá-OTRI
Universidad de Alcalá-OTRI
Universidad de Alcalá-OTRI

Description of the technology

The present invention provides the preparation of active nanoconjugates against advanced prostate cancer and to prevent metastasis.

The formation of the nanoconjugates is carried out by mixing in solution, preferably aqueous in the presence or absence of buffer, the dendritic molecules and the corresponding peptides, in the proportion of interest.

These systems are formed by dendritic molecules (dendrimers and dendrons) and neuropeptides. Preferably, the dendritic macromolecules are of carbosilane structure, mainly with cationic functions in the periphery, and the neuropeptides are of the glucagon / secretin family, mainly VIP, GHRH and PACAP. These nanoconjugates are formed by combining the dendritic molecule and the corresponding peptide in the necessary proportion.

The present invention also relates to the biomedical uses of the peptide / dendritic molecule combinations.

Preferably this invention is for the development of drugs for the treatment of prostate cancer. However, other types of cancers are not excluded. Examples of pharmaceutical preparations include any solid composition (tablets, pills, capsules, granules, etc.) or liquid (gels, solutions, suspensions or emulsions) for oral, nasal, topical or parenteral administration.

Current development status

Experimental technologies

Applications

Preferably this invention is for the development of drugs for the treatment of prostate cancer. However, other types of cancers are not excluded. Examples of pharmaceutical preparations include any solid composition (tablets, pills, capsules, granules, etc.) or liquid (gels, solutions, suspensions or emulsions) for oral, nasal, topical or parenteral administration.

Desired business relationship

Technology selling

Patent licensing

Technology development

The research group seeks for companies from the Biomedicine, Pharmaceutical and Health sector, to establish licensing agreements, cooperation agreements or commercial agreements with technical assistance.

Intellectual property status

Patent already applied for
P201700069
OEPM Spain

Technology Owner

Universidad de Alcalá-OTRI

Research & Technology Organization

Related keywords

  • Biological Sciences
  • Medicine, Human Health
  • Clinical Research, Trials
  • Cytology, Cancerology, Oncology
  • Medical Research
  • Pharmaceutical Products / Drugs
  • Biology / Biotechnology
  • Biochemistry / Biophysics Technology
  • Cellular and Molecular Biology Technology
  • Molecular design Technology
  • Genetic Engineering / Molecular Biology
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Medical Health related
  • Therapeutic
  • Other Medical/Health Related
  • cancer
  • metastasis
  • peptide
  • dendrons
  • prevention
  • prostate
  • anticancer
  • dendrimers
  • carbosilane
  • pc3
  • dendritic molecules

About Universidad de Alcalá-OTRI

Research & Technology Organization from Spain

The Technology Transfer Office at Alcalá University serves as a liaison between the University and its socioeconomic environment in terms of research and innovation. It encorages collaboration between research groups from universities and companies/institutions, with the objective to promote and commercialize research results and scientific capabilities.

Some of the services offered by this office are specified in the following list:

- Promotion of R & D and improvement of the relationships with companies.
- Promote the participation in R & D projects applicants to public calls (regional, national and European).
- Advising, processing and monitoring of patents and other forms of industrial protection.
- Support in the negotiation of contracts and agreements for R&D&i

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.